The QualityStocks Daily Thursday, March 28th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(AVTX) $21.7500 +357.89%

SeriousTraders(SGTM) $2.3000 +58.62%

AllPennyStocks(MESO) $5.0100 +43.55%

The QualityStocks Daily Stock List

Avalo Therapeutics (AVTX)

QualityStocks, Zacks, Early Bird and MarketBeat reported earlier on Avalo Therapeutics (AVTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Avalo Therapeutics Inc. (NASDAQ: AVTX) (FRA: C6K0) is a clinical stage medicine firm that is focused on discovering, developing and commercializing therapeutics for patients with unmet clinical needs in rare genetic, immune-oncology and immunology illnesses.

The firm has its headquarters in Rockville, Maryland and was incorporated in 2011, on January 31st by Solomon H. Snyder, Barbara S. Slusher, Isaac Blech and Blake M. Paterson. Prior to its name change in August 2021, the firm was known as Cerecor Inc. It operates as part of the scientific research and development services industry and serves consumers around the world.

The company uses a precision medicine approach to develop and commercialize highly targeted therapeutics. It operates a bioassay facility in Germantown.

The enterprise’s product pipeline is made up of an anti-light mAb dubbed AVTX-002, which targets immune-inflammatory ailments like moderate-to-severe inflammatory bowel disease and acute respiratory distress syndrome. It also offers an anti-IL-18 mAb, which targets immune-inflammatory and immune-oncology illnesses like Still’s disease and multiple myeloma. Still’s disease is a disorder that’s characterized by arthritis, a rash, high spiking fevers and inflammation. In addition to this, the enterprise also develops AVTX-801, AVTX-802 and AVTX-803, which are therapeutic monosaccharide therapy doses indicated for congenital disorders of glycosylation; and a dual mTORc1/c2 inhibitor dubbed AVTX-006, which targets lymphatic malformations.

The firm is focused on addressing the significant unmet medical need for patients and advancing its programs, having recently expanded its AVTX-002 program. Meeting these needs will not only extend the firm’s consumer reach but also encourage more investments into the firm, which will be good for its growth.

Avalo Therapeutics (AVTX), closed Thursday's trading session at $21.75, up 357.8947%, on 31,910,412 volume. The average volume for the last 3 months is 131,096 and the stock's 52-week low/high is $3.9501/$1130.40.

Athena Bitcoin Global (ABIT)

We reported earlier on Athena Bitcoin Global (ABIT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Athena Bitcoin Global (OTC: ABIT) is a digital asset tech firm that operates a network of cryptocurrency ATMs in North America and South America.

The firm has its headquarters in Chicago, Illinois and was incorporated in 1981, on August 26th by Sam Sesay. Prior to its name change, the firm was known as GamePlan Inc. It operates as part of the securities and commodity contracts intermediation and brokerage industry. The firm has two companies in its corporate family and serves consumers around the globe.

The company mines cryptocurrencies, with a focus on the generation of digital assets and the blockchain ecosystem. Its objective is to build open financial systems that serve the global community. The company’s solutions allow the opportunity and freedom to invest, spend, build and save.

The enterprise has developed a financial platform known as Athena RURU, which facilitates the use of digital currencies and electronic banking to power economies. Its peer-to-peer exchanges, i.e. MercadoAthena.com and BitQuick.com, allow individuals to sell and buy bitcoin and bitcoin cash without using an ATM. The enterprise also offers advisory services on a range of fixed income and equity transactions for real estate developers and firms. Its Bitcoin locations include El Salvador, Colombia, Argentina, Texas, Puerto Rico, Pennsylvania, Ohio, Missouri, Michigan, Illinois, Georgia, Florida, California and Alabama. The enterprise also operates a foundation for middle school and high school students.

The firm is focused on building alliances for a better financial world, which will not only bring in more opportunities for investment and growth but also benefit its shareholders.

Athena Bitcoin Global (ABIT), closed Thursday's trading session at $0.13396, up 33.96%, on 944,054 volume. The average volume for the last 3 months is 207,370 and the stock's 52-week low/high is $0.0402/$0.44.

CASI Pharmaceuticals (CASI)

MarketBeat, MarketClub Analysis, StockMarketWatch, TraderPower, QualityStocks, InvestorPlace, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, StreetInsider, 360 Wall Street, The Online Investor, TradersPro, FreeRealTime, BUYINS.NET and PoliticsAndMyPortfolio reported earlier on CASI Pharmaceuticals (CASI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CASI Pharmaceuticals Inc. (NASDAQ: CASI) (FRA: ENMN) is a biopharmaceutical firm that is engaged in the acquisition, development and commercialization of pharmaceutical products and innovative therapeutics that address various unmet medical needs.

The firm primarily operates in China, Canada and the United States as well as internationally, and serves patients across the globe. CASI Pharmaceuticals has its headquarters in Rockville, Maryland and was established in 1991. The firm was known as EntreMed Inc. before changing its name in 2014 to CASI Pharmaceuticals Inc.

CASI Pharmaceuticals is engaged in building a pipeline through various business development transactions that are mutually beneficial and develops as well as commercializes its drug candidates in Macau, Hong Kong, Taiwan and China. The firm is party to distribution agreements with Riemser Pharma GmbH, Pharmathen Global BV and China Resources Guokang Pharmaceuticals Co. Ltd as well as licensing agreements with Cleave Therapeutics Inc., Black Belt Therapeutics Ltd, BioInvent International AB and Juventas Cell Therapy Ltd.

CASI Pharmaceuticals Inc.’s product pipeline includes an IV formulation which is administered to multiple myeloma patients before stem cell transplantation as a conditioning treatment, known as EVOMELA. The majority of the firm’s revenue is generated from the product sales of this particular candidate, which recently concluded phase 1 clinical studies in China. The company’s other products include an investigative product indicated for the treatment of B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia called CNCT19; a treatment indicated for myelodysplastic syndrome, acute myeloid leukemia, lymphomas and solid tumors, dubbed CB-5339; a treatment for multiple myeloma christened CID-103; a treatment for Philadelphia chromosome-negative ALL in adult patients called MARQIBO; a treatment for non-Hodgkin’s lymphoma patients dubbed ZEVALIN and BI-1206, which is undergoing a phase 1/2 trial in combination with Keytruda, an anti-PD1 therapy, for the treatment of solid tumors.

CASI Pharmaceuticals (CASI), closed Thursday's trading session at $3.61, up 20.3333%, on 127,150 volume. The average volume for the last 3 months is 63,713 and the stock's 52-week low/high is $1.71/$8.48.

Phoenix New Media (FENG)

StreetInsider, MarketClub Analysis, StockTradersHQ, MarketBeat, Marketbeat.com, Profit Confidential, The Street, StockMarketWatch, INO.com Market Report, QualityStocks, OTCJournal, BUYINS.NET, CoolPennyStocks, Hit and Run Candle Sticks, HotOTC, WealthMakers, Investment Contrarians, MadPennyStocks, Wall Street Mover, Uncommon Wisdom, TopStockAnalysts, PoliticsAndMyPortfolio, National Inflation Association, StockRich, PennyInvest, PennyStockVille, BullRally, StreetAuthority Daily, Zacks, Rick Saddler, Seeking Alpha, Stock Stars, StockEgg, Street Insider and MonsterStocksPicks reported earlier on Phoenix New Media (FENG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Phoenix New Media Ltd (NYSE: FENG) (FRA: 1PXA) is a media firm that is engaged in the provision of content on an integrated platform across TV, mobile and internet channels.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 1998. It operates as a subsidiary of Phoenix Satellite Television Holding Ltd. The firm serves consumers in China.

The company operates through the Paid Services and Net Advertising Services segments. It allows consumers to share user-generated content through their mobile devices and on the internet as well as access professional news and other information.

The enterprise provides content and services through 3 channels, which include the mobile channel, PC channel and telecom operators. It also transmits its content to TV viewers, mainly through Phoenix TV. The enterprise also offers about forty interest-based verticals, including real estate, PC digital reading, history, sports, military affairs, we-media, live broadcasting, automobiles, entertainment, fashion, finance and news, through its site, ifeng.com. This is in addition to providing interactive services, which include user surveys and comments posting. The enterprise’s mobile channel comprises of a news application dubbed ifeng News, which offers newsfeeds and other content in the form of live broadcasting, image, video and text.

The firm recently announced its latest financial results, with its CEO noting that they were committed to developing their core competitive differentiation in original content production capabilities. The firm remains focused on aligning its business with shifting industry dynamics and elevating its brand influences by delivering original content consistently, which will be good for its investments.

Phoenix New Media (FENG), closed Thursday's trading session at $1.94, up 19.7531%, on 340,298 volume. The average volume for the last 3 months is 219,096 and the stock's 52-week low/high is $1.10/$4.14.

Celcuity Inc. (CELC)

MarketBeat, InvestorPlace, QualityStocks, TradersPro, MarketClub Analysis, BUYINS.NET, StreetInsider, StockMarketWatch, Profitable Trader Authority, PennyStockScholar, PennyStockProphet and OTCtipReporter reported earlier on Celcuity Inc. (CELC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Celcuity Inc. (NASDAQ: CELC) is a clinical-stage biotechnology firm that is engaged in developing molecularly targeted therapies for patients with cancer.

The firm has its headquarters in Minneapolis, Minnesota and was incorporated in January 2012 by Lance G. Laing and Brian F. Sullivan. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm serves consumers in the United States.

The company is party to a license agreement with Pfizer Inc., which entails developing and commercializing rights to Gedatolisib. It designs technology to identify abnormal cellular processes in order to treat cancer.

The enterprise has designed a diagnostic platform dubbed CELsignia, which uses living tumor cells from a patient to identify a particular abnormal cellular process driving an individual’s cancer and the associated targeted therapy for the treatment. It also develops a qualitative lab-developed test dubbed the CELsignia MP test, which measures P13K, c-Met and HER2 signaling activity in ovarian and breast cancer tumor cells. Its drug candidates include a formulation dubbed Gedatolisib, which targets different class I P13K isoforms and mammalian targets of rapamycin. It is focused on treating patients with HER2-negative, hormone receptor positive and metastatic or advanced breast cancers.

The firm is focused on submitting its Gedatolisib formulation in the future to the FDA for a New Drug Application in treating a broad patient population. The success and approval of this drug will bring in additional revenues as well as investments into the firm, which will be good for its growth.

Celcuity Inc. (CELC), closed Thursday's trading session at $21.6, up 18.9427%, on 606,291 volume. The average volume for the last 3 months is 2,786 and the stock's 52-week low/high is $8.389/$22.188.

Spirent Communications (SPNUF)

We reported earlier on Spirent Communications (SPNUF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spirent Communications Plc (OTC: SPNUF) (OTC: SPMYY) (LON: SPT) (FRA: BW8) is a company focused on providing automated test and assurance solutions.

The firm has its headquarters in Crawley, the United Kingdom and was incorporated in 1936 by Jack Bowthorpe. Prior to its name change in May 2006, the firm was known as Spirent Plc. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers in Europe, the Americas, the Asia Pacific, Africa and the Middle East.

The company operates through the Lifecycle Service Assurance and Networks & Security segments. The Lifecycle Service Assurance segment offers testing solutions for 5G mobile core networks, and cellular and Wi-Fi devices in the lab, as well as live solutions. On the other hand, the Networks & Security segment develops test methodologies, tools, and services for virtualized networks, cloud, and proactive security validation. Its portfolio of products and services addresses the test, assurance, and automation challenges of a new generation of technologies, such as 5G, software-defined wide area networking (SD-WAN), cloud, autonomous vehicles, and others. The company’s products and services cover testing needs beginning with lab validation of new technology and extending to acceptance and benchmarking in live networks. It caters to the transportation, defense, government, healthcare, aerospace and automotive, among other industries.

The firm recently entered into a collaboration agreement with Cadence to bring advanced chipset testing to pre-silicon verification. This move may open it up to new growth and investment opportunities and create new avenues to generate revenues. This is in addition to generating returns for its shareholders.

Spirent Communications (SPNUF), closed Thursday's trading session at $2.47, up 17.619%, on 131,373 volume. The average volume for the last 3 months is 262,400 and the stock's 52-week low/high is $1.10/$2.56.

Dogness International (DOGZ)

TradersPro, MarketClub Analysis, QualityStocks, StreetInsider, TopPennyStockMovers, StockMarketWatch, Schaeffer's, InvestorPlace and FreeRealTime reported earlier on Dogness International (DOGZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dogness International Corp. (NASDAQ: DOGZ) is focused on designing, manufacturing and selling smart and fashionable products for pets.

The firm has its headquarters in Dongguan, the People’s Republic of China and was incorporated in 2003 by Shilong Chen. The firm serves consumers around the globe.

The company’s objective is to build the future of pet commerce by innovating its traditional product line while leveraging its proven research and development capabilities to gain leadership in pet Internet of Things. It produces high-quality harnesses, collars and leashes that are comfortable, beautiful and designed to ensure pet owners’ peace of mind and pet safety. The company operates through its subsidiaries.

The enterprise produces products in Special function, Holiday, LED, Luxury, Elegance, Cat and Classic series. They include pet harnesses, pet collars, retractable leashes, lanyards and pet leashes; pet belt ribbons, elastic belts, laces, high-grade textiles and computer jacquard ribbons; gift suspenders; pet charms and mouth covers; climbing hooks; pet shampoos; and intelligent pet products like pet water fountains, app-controlled pet feeders and smart pet toys. It also provides the anti-shock leash, the H2 smart harness and the C2 smart collar. The enterprise has designed its smart collars to allow owners to find their dogs easily. It provides its products to retailers and wholesalers.

The company recently announced that it would be expanding the availability of its smart pet products online and in stores, building on its existing supplier relationships. This move will help extend the company’s consumer reach, which will not only bring in more revenue into the company but also drive its growth.

Dogness International (DOGZ), closed Thursday's trading session at $5.81, up 16.6667%, on 42,943 volume. The average volume for the last 3 months is 2,414 and the stock's 52-week low/high is $2.785/$23.60.

StageZero Life Sciences (SZLSF)

StockEarnings reported earlier on StageZero Life Sciences (SZLSF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

StageZero Life Sciences Limited (OTCQB: SZLSF) (TSE: SZLS) (FRA: 61N1) is a vertically integrated healthcare firm focused on the development and commercialization of proprietary molecular diagnostic tests for the early detection of illnesses and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

The firm has its headquarters in Richmond Hill, Canada and was incorporated in 1997, on February 20th by K. Wayne Marshall and Choong-Chin Liew. It operates as part of the diagnostics and research industry, under the healthcare sector. The firm serves consumers around the world.

The company is focused on minimizing the risk of cancer and other chronic illnesses through early detection and intervention. Through CareOncology, it has partnered with The Source Functional Nutrition group to add another pillar to the cancer care setting; nutritional guidance for cancer patients.

The enterprise's proprietary platform technology, Sentinel Principle, has been designed to identify RNA-based biomarkers from whole blood. Its lead product, Aristotle, is an mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. It also provides BreastSentry, a test to determine a woman's risk for developing breast cancer; ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; COVID-19 Tests; and the Prostate Health Index, a screening test for prostate cancer.

The firm, which recently released its latest financial results, remains committed to building partnerships to broaden its reach and market penetration. This may bring in additional revenues into the firm while opening it up to new growth and investment opportunities.

StageZero Life Sciences (SZLSF), closed Thursday's trading session at $0.03505, off by 12.375%, on 20,500 volume. The average volume for the last 3 months is 2.158M and the stock's 52-week low/high is $0.027/$0.06568.

Momo Inc. (MOMO)

StocksEarning, MarketClub Analysis, InvestorPlace, Schaeffer's, StockEarnings, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, QualityStocks, Kiplinger Today, Trades Of The Day, Daily Trade Alert, StreetInsider, The Street Report, Marketbeat.com, BUYINS.NET, The Online Investor, FreeRealTime, INO.com Market Report, Wealth Insider Alert, TopStockAnalysts, StreetAuthority Daily, Trading Concepts, TradersPro, Louis Navellier, Investopedia, Money Morning, PennyDoctor, Greenbackers, TipRanks, StockMarketWatch, StocksImpossible, Street Insider, Daily Wealth, DividendStocks, ChineseWire, CrashTrade, OTCBB Journal, Early Bird, Barchart, First Penny Picks, ChartAdvisor, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A new poll by the National Research Group (NRG) has revealed that 42% of television and film production professionals are worried about artificial intelligence (AI) technology “harming people in the entertainment field. On the other hand, close to one-third (32%) of the professionals polled said they believe AI technology will benefit them.

The remaining 24% said they believed AI would not have an impact or that they still didn’t know the potential impact of the disruptive technology on the entertainment industry. With AI technology advancing significantly over the past couple of years, many professionals across various industries have felt an increasing sense of disquiet over the potential of being replaced with AI.

After only a few years in the market, generative artificial intelligence tools have shown that they can disrupt creative industries in a major way. AI generative text, art and now video are becoming increasingly indistinguishable from the real thing, and many worry that humans could soon be removed from the equation in favor of AI.

The February 2024 poll surveyed more than 1,500 “creative class professionals” aged 18 to 64 who work either part-time or full-time in positions that call for “high degrees of creativity and autonomy.” This accounts for roughly 31% of America’s labor market.

TV commercial director Michael Malagon notes that while generative AI is a powerful tool, its potential is enhanced even further when it is used by creative professionals with storytelling knowledge and experience. Creatives such as writers and directors can use their intimate understanding of storytelling coupled with skills they’ve built up through the years to use AI-generated tools and content more effectively.

Consequently, Malagon believes that people will remain critical to the creative filmmaking process even with the advancement of generative artificial intelligence. On the other end of the spectrum, filmmaking duo Daniel Scheinert and Daniel Kwan who directed the award-winning film “Everything Everywhere All at Once” aren’t as enthusiastic about generative AI.

During a recent SXSW talk, Kwan said that he was “terrified” of artificial intelligence. Still, it will likely be a long time before directors lose their jobs to AI.

In the meantime, however, freelancers are much more likely to be impacted by generative AI. The survey showed 49% of the creative class freelancers polled said that AI will reduce the amount of available work, and those in the music industry and creative writing fields were most concerned about losing work to AI.

Entities such as Momo Inc. (NASDAQ: MOMO) are bringing innovative AI solutions to the market to enrich not just video sharing but also ease radio and TV production. Those concerned about losing work to AI may need to change their focus and appreciate the ways in which these technologies can ease or even improve the work that they do.

Momo Inc. (MOMO), closed Thursday's trading session at $6.21, off by 0.480769%, on 2,176,258 volume. The average volume for the last 3 months is 722,149 and the stock's 52-week low/high is $5.59/$11.12.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, PsychedelicNewsWire, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Governor Eric Holcomb of Indiana recently signed a measure that includes provisions to fund clinical trials on psilocybin’s therapeutic benefits. The measure, which primarily focuses on healthcare issues, was recently amended to include language on psychedelics.

The reform provisions that legislators included to the broader measure were obtained from a standalone bill from Senator Ed Charbonneau, which cleared the Senate in February. In a press release, Charbonneau stated that the bill’s intention was to provide funds to help research institutions in the state in conducting research on the possible use of psilocybin in the treatment of mental-health conditions, with a focus on first responders and veterans.

Under the recently signed law, Indiana will establish a therapeutic psilocybin research fund to provide the aforementioned financial assistance. Any trial that obtains funding under the bill will need to include first responders and veterans in their study sample. The procedure to receive funding involves an application made by researchers to the state’s health department.

Eligible conditions for research include anxiety, PTSD, bipolar disorder, depression, migraines and chronic pain, as well as tobacco use disorder and alcohol use disorder. The trials conducted using provided funds will need to compare the effectiveness of psilocybin as a treatment for mental-health conditions with the effectiveness of currently used treatment options.

Officials are expected to come up with a process to administer the fund and process applications by July 1, 2024.

This development comes after a study committee suggested, during this year’s legislative session, that legislators authorize a psilocybin pilot program to study psychedelic-assisted therapy for mental health. The committee, which was established by the state, advised that the general assembly adopt an approach that focused on research, access and prudence.

The committee then noted that psilocybin had proven medical benefits and shouldn’t be classified as a Schedule I drug. At the federal level, psilocybin is illegal and is classified as a Schedule I substance under the Controlled Substances Act.

Indiana is one of many states where legislators are pursuing psychedelic reform, with a focus on therapeutic access and research. In Arizona, a House panel passed a Senate-approved measure to legalize psilocybin therapy centers where individuals could receive the drug in a supervised setting. In Maryland, the Senate and House approved a bill to establish a psychedelics task force that would conduct research on possible regulatory frameworks for therapeutic access to psychedelics like mescaline, psilocybin and DMT.

Legislators in Utah also recently passed a measure that would authorize a pilot program for hospitals to administer MDMA and psilocybin as alternative treatment options. The measure was forwarded to the governor’s desk. The research fund in Indiana facilitating psilocybin research could uncover scientific data that adds onto what for-profit enterprises such as Compass Pathways PLC (NASDAQ: CMPS) are doing to advance the field of psychedelic medicine.

Compass Pathways PLC (CMPS), closed Thursday's trading session at $8.32, off by 12.4211%, on 3,563,752 volume. The average volume for the last 3 months is 235,608 and the stock's 52-week low/high is $5.01/$12.75.

Innovative Industrial Properties Inc. (IIPR)

InvestorPlace, Kiplinger Today, Top Pros' Top Picks, The Online Investor, QualityStocks, Schaeffer's, Daily Trade Alert, The Street, MarketBeat, Wealth Insider Alert, Trades Of The Day, DividendStocks, The Wealth Report, Zacks, TradersPro, StreetInsider, Stock Up Featured, FreeRealTime, StockMarketWatch, Stock Gumshoe, CFN Media Group, The Street Report, Investopedia, Trading Concepts, Early Bird, Outsider Club, Marketbeat.com, TipRanks, VectorVest, Wealth Daily and StreetAuthority Daily reported earlier on Innovative Industrial Properties Inc. (IIPR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kathy Hochul, the governor of New York, has issued an order to reassess the state’s adult-use cannabis licensing program due to various setbacks. Those hurdles, including lawsuits and administrative challenges, have not only stood in the way of the legal marijuana market but have also led to the proliferation of illicit sellers.

The assessment aims to identify ways to expedite license processing and facilitate quicker business openings. Additionally, the assessment will conduct a comprehensive review of the state’s Office of Cannabis Management’s (OCM) organizational structure and procedures.

Hochul, a member of the Democratic Party, has openly complained about the launch process of recreational cannabis in the state, referring to it as a failure. Since the commencement of sales in 2022, just a little more than 80 legal dispensaries have been established.

The initial phase of the legalization law allocated retail licenses exclusively to nonprofit organizations and people with previous cannabis-related convictions. Additionally, it introduced a $200 million equity fund aimed at assisting applicants adversely impacted by the drug war in setting up dispensaries.

However, the licensing procedure encountered legal obstacles and implementing the equity fund faced delays, thereby impeding the legal marijuana market from thriving. Consequently, unauthorized dispensaries began to emerge throughout the state, particularly in New York City. The situation became so problematic that Hochul requested online platforms such as Yelp and Google refrain from listing these illegal establishments.

Despite efforts to regulate the market, the regulatory bodies struggled to cope with the overwhelming number of license applications. The OCM, responsible for processing licenses, has only 32 employees dedicated to reviewing applications, while it has received about 7,000 applications last year.

This decision to review the program came shortly after a senior official at the agency was sent on administrative leave after allegations from the NY Cannabis Insider that the agency had exhibited biased enforcement practices, particularly targeting a cannabis processor. Commissioner Jeanette Moy of the Office of General Services, along with other state officials,  will spend at least 30 days immersed in the agency as part of the assessment process. Together, the team will develop plans to improve the agency’s operations and set performance standards for subsequent projects.

OCM’s executive director, Chris Alexander, acknowledged the progress made in building an equitable marijuana market but emphasized the need for improvement in the agency’s operations. He expressed confidence in Moy’s leadership abilities and her capacity to steer the agency in the right direction.

The delays in having a flourishing legal marijuana market in New York is potentially stifling opportunities for local ancillary companies operating similar to Innovative Industrial Properties Inc. (NYSE: IIPR) that would have sprouted and carved out a niche for themselves in this state.

Innovative Industrial Properties Inc. (IIPR), closed Thursday's trading session at $103.54, off by 0.776234%, on 255,039 volume. The average volume for the last 3 months is 37,932 and the stock's 52-week low/high is $63.3587/$105.81.

Ideal Power Inc. (IPWR)

TradersPro, StockMarketWatch, MarketBeat, TraderPower, BUYINS.NET, Trading Concepts, Trades Of The Day, Total Wealth, StreetInsider, Street Insider, Prism MarketView, MarketClub Analysis, Marketbeat.com and Early Bird reported earlier on Ideal Power Inc. (IPWR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ideal Power (NASDAQ: IPWR), a company pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN(TM) bidirectional semiconductor power switch, has priced its previously announced underwritten public offering. The offering, which is anticipated to close today, consists of 2,000,000 shares of its common stock (or prefunded warrants in lieu thereof) at $7.50 per share of common stock. The public offering is expected to result in an estimated $15 million in gross proceeds before standard deductions are made. Ideal Power anticipates using the funds for general corporate and working capital purposes. The company also noted that it has granted to the underwriter a 30-day option to purchase up to 300,000 additional shares of common stock on the same terms and conditions. Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/HClDY

About Ideal Power Inc.


Ideal Power is pioneering the development and commercialization of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy-control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (“B-TRAN”) semiconductor technology. B-TRAN is a unique double-sided bidirectional AC switch that delivers substantial performance improvements over today's conventional power semiconductors. Ideal Power's B-TRAN can reduce conduction and switching losses, complexity of thermal management and operating cost in AC power switching and control circuitry. For more information about the company, visit www.IdealPower.com

Ideal Power Inc. (IPWR), closed Thursday's trading session at $8.9, up 0.451467%, on 31,337 volume. The average volume for the last 3 months is 3,278 and the stock's 52-week low/high is $6.61/$13.98.

The QualityStocks Company Corner

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

The cannabinoid market value in 2023 was $22.23 billion and is expected to grow at a CAGR of 15.3%, resulting in an estimated market value of $60.36 billion

The global mass spectrometry market will reach $6.77 billion in 2024 and is expected to grow at a CAGR of 6.25%, reaching $9.17 billion by 2029.

Astrotech and subsidiary AgLAB Inc. are using mass spectrometry to boost the profitable yield of hemp and cannabis production

The United States has seen a rising awareness of the health and therapeutic benefits of cannabinoids, prompting an expected market increase of 15.3%, from $22.23 billion in 2023 to an anticipated $60.36 billion by 2030 (https://cnw.fm/srapD). Focused on optimizing and improving higher yields, Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly-owned subsidiary AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market.

A legislative committee in Nebraska has approved a measure that would impose a 100% tax on CBD and hemp products in the state. The committee approved the bill in a 7 to 0 vote. It is expected that the state's unicameral legislature will take up the proposed legislation later this week. According to the bill's sponsor, Senator Lou Ann Linehan, this tax hike is focused on bringing in additional funds to help offset property tax bills. The bill also includes reforms such as the elimination of sales tax exemptions on candy, soda, pet services, lottery tickets and ad revenue. This is expected to bring in more than $180 million in new revenue for Nebraska. The evolving laws on hemp and CBD products could over time create a vibrant market for instrumentation companies such as Astrotech Corp. (NASDAQ: ASTC) that design and commercialize different equipment, such as process control solutions targeting facilities that manufacture products from hemp.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Thursday's trading session at $8.9499, up 1.7034%, on 2,186 volume. The average volume for the last 3 months is 32,402 and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

Longeveron recently released its full-year results for the period ended December 31, 2023, and provided a corporate update

The update outlined the company's plans to prioritize the development of Lomecel-B(TM) in Hypoplastic Left Heart Syndrome ("HLHS"), a rare, pediatric congenital heart condition characterized by an underdeveloped left side of the heart

Longeveron plans to complete the enrollment in the ELPIS II trial for HLHS in 2024

The company also reported that it is exploring opportunities to advance its Alzheimer's disease program through potential partnerships or other sources of funding

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron's lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year.

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.

Lomecel-B™

Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306
Email: mmoyer@lifesciadvisors.com

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Thursday's trading session at $3.25, up 4.5016%, on 154,226 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $15.11/$.

Recent News

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0)

The QualityStocks Daily Newsletter would like to spotlight Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0).

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is speaking out about the need for greater data privacy from large technology platforms monitoring and data exploitation. The company noted that big-tech platforms, such as email providers, VPNs and messaging platforms, can access and analyze users' data, private communications and personal information; these companies often do this without explicit knowledge or consent. Sekur Private Data provides solutions designed to protect data and prevent data exploitation. Those solutions include SekurRelay Enterprise Email Solution, which empowers corporate executives and management to effortlessly implement enhanced security measures for their company's email domain; SekurVPN, which sets new industry standards by utilizing a proprietary infrastructure and abstaining from hyperscaler or big-tech hosting providers; and SekurMessenger, which uses strict vetting system that prevents nonvetted users from spamming and hacking your account. "Covert data collection and surveillance practice raises serious privacy concerns and undermines individuals' control over their digital footprint," said the company in the press release. "Additionally, data harvested by third-party companies is not protected or handled in a secure and private manner, and this creates a large security risk as hackers gain access to millions of users' personal information through their cyber-attacks, as evidenced by daily news on cyber-attacks on health care platforms, banking and credit platforms and more. The rise of social media platforms, and advanced AI systems, has exacerbated the threat of personal data being harvested, misused or even censored. Individuals' online presence and interactions are constantly monitored, with their private information often exploited for commercial gain, or subjected to sometimes biased algorithmic manipulation. What sets Sekur Private Data apart is its strict data privacy standards adhering to Swiss federal laws by hosting data exclusively in Switzerland, a country with some of the world's strongest privacy laws, which safeguards users against intrusive data requests and monitoring from big tech giants."

To view the full press release, visit https://ibn.fm/ARyhZ

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website at www.Sekur.com, approved distributors, and telecommunications companies. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.

Customer information is completely confidential and safely stored in Switzerland using military grade security. All data, whether physical, network-based or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most United Nations organizations, as well as many corporations and governmental organizations. All user data is protected by the Swiss Federal Data Protection Act and the Swiss Federal Data Protection Ordinance, which offer some of the strongest privacy protection in the world for both individuals and organizations.

The company owns 100% of its own infrastructure and, unlike its competitors, does not rely on third party cloud services like Amazon Web Services, Microsoft Azure Cloud or Google cloud infrastructure.

Sekur Private Data has chosen Switzerland to locate its data storage because of the country’s neutrality, independence, strong privacy laws, long standing political stability and excellent international relations. Switzerland is also home to several large multinational corporations and is ranked as having one of the strongest and most competitive economies in the world.

The company is headquartered in Toronto, Ontario.

Products

Sekur Private Data distributes a privacy communications suite offering encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application. All solutions cater to consumers, SMBs, enterprises and governments.

  • SekurMail® is an encrypted email service offering a private, safe and powerful tool to communicate with everyone, either within the Sekur ecosystem or outside. SekurMail protects personal information and communications from being accessed by unauthorized parties. Its encryption and other security measures prevent messages from being intercepted, modified or tampered with, either in transit or while stored. SekurMail empowers the client to access information and communicate with anyone in the world, regardless of geographical or political barriers.
  • SekurVPN® creates a secure, encrypted connection between the client’s device and the Internet, giving clients access to the web safely and privately by routing their connections through a server and hiding their online actions. All the data sent and received is hidden from prying eyes. This includes the clients’ Internet Service Providers, as well as potential hackers and even government surveillance agencies. It can also help clients bypass geographical restrictions and censorship.
  • SekurMessenger® is a Swiss-hosted private and secure messaging communications app providing secure and private chat, self-deleting chat, voice recording and file transfer via any mobile device, tablet or desktop computer. Communications are transmitted only within secure servers. It’s designed for organizations that need to protect their flow of information and secure their communications with customers and partners. SekurMessenger is designed to provide military-grade encryption and privacy by ensuring that only the sender and intended recipient can read the messages exchanged. It works for both licensed users of the app and intended message recipients who do not have the app.

Market Opportunity

An analysis from ReportLinker forecasts that the global cybersecurity market will grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors that are driving cybersecurity market growth, according to the report.

The global data privacy software market was estimated to be worth $1.68 billion in 2021 and is expected to grow from $2.36 billion in 2022 to $25.85 billion by 2029, achieving an eye-popping 40.8% CAGR during the forecast period, according to a Fortune Business Insights report titled ‘Data Privacy Software Market 2022-2029’.

The widespread shift toward remote working culture, evolving government data privacy regulations and the rapidly increasing adoption of Internet-of-Things devices are among the major factors propelling market growth, per the report.

Management Team

Alain Ghiai is founder, CEO and Director at Sekur Private Data. He also founded GlobeX Data S.A. (GDSA) in 2007 and has served as Director and CEO since then. He founded GlobeX Data Inc. (GlobeX US) in August 2012 and has served as Director and CEO since that time. He attended the California College of Arts in San Francisco, where he earned a Bachelor of Architecture. He has over 15 years of experience in the software industry and was instrumental in taking Sekur Private Data public in July 2019.

Scott Davis, CPA, CGA, is CFO at Sekur Private Data. He is also a partner at Cross Davis & Company LLP Chartered Professional Accountants. His experience includes CFO positions at several companies listed on the TSX Venture Exchange. He spent four years at Appleby as an Assistant Financial Controller. Prior to that, he spent two years at Davison & Company Chartered Professional Accountants as Auditor, five years with Pacific Opportunity Capital as Accounting Manager and two years at Jacobson Soda and Hosak, Chartered Professional Accountants. He obtained his CPA, CGA in 2003.

Learn more about the company’s management team by visiting its corporate page.

Sekur Private Data Ltd. (OTCQB: SWISF), closed Thursday's trading session at $0.0487, up 0.205761%, on 49,510 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0394/$0.1576.

Recent News

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF)

The QualityStocks Daily Newsletter would like to spotlight Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) .

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, is releasing additional drill results from its ongoing infill and step out drill program at the Kairuni zone on its Oko West project in Guyana. According to the report, Hole D-380 intersected 39.7 meters at 5.27 grams per tonne of gold ("Au") from 152.3 meters downhole, including 3.8 meters at 14.18 g/t Au and 13.0 meters at 10.50 g/t Au. Reunion Gold called the results encouraging and noted that they indicate "potential for additional high-grade mineralized shoots to be defined in areas of existing wider drill spacing where the current infill continues." Other results showed that drill hole D-392 intersected 70.3 meters at 1.08 g/t Au from 193.0 meters downhole, including 12.0 meters at 3.42 g/t Au and, in Block 4, Hole D-377 intersected 55.0 meters at 2.42 g/t Au from 645 m downhole including 5.5 meters at 5.97 g/t Au and 20.4 meters at 3.42 g/t Au. Reunion Gold currently has eight diamond drill rigs operating at the Oko West project, with five rigs focused on Blocks 1, 4, 5 and 6; two rigs carrying out geotechnical and hydrogeological drilling related to potential infrastructure sites on the project; and one rig conducting drill testing exploration targets outside of the MRE area in search of potential satellite resources. "It is encouraging to see these strong exploration results from the Block 6 area as the company continues to advance along its dual track strategy of continuing its exploration programs while at the same time rapidly advancing Oko West down the development path," said Reunion Gold president and CEO Rick Howes in the press release. "The PEA remains on track for release by the end of Q2 2024. On the exploration front, the addition of new datasets is allowing our exploration team to target more effectively within other areas of the Oko West project area. Alongside this, Reunion is continuing to evaluate and define new properties for further exploration in both Guyana and Suriname."

To view the full press release, visit https://ibn.fm/w5oOA

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) is a leading gold explorer in the Guiana Shield, South America. In early 2021, the Company announced an exciting new greenfield gold discovery at its Oko West project in Guyana, where, after 22 months of resource definition drilling, the Company has announced an initial Mineral Resource Estimate (MRE) containing 2.475 Moz of gold in Indicated resources at 1.84 g/t and 1.762 Moz of gold in inferred resources at 2.02 g/t contained within a pit shell outline. Preliminary metallurgy results performed by the company, consisting of 8 bottle roll tests obtained strong results, averaging just under 90% recoveries on average. The Company is continuing with additional development activities at Oko West, including environmental base line studies and additional metallurgical work relating to the delivery of a PEA by year end 2023. In addition, Reunion Gold is currently exploring several priority targets in the Oko West project area on which the company feels there is good potential to add additional resource ounces. This includes the opportunity to grow the initial mineral resource estimate (MRE) released on June 13, 2023, and to discover additional gold ounces at Oko West outside of the resource area.

The Guiana Shield remains one of the most prospective exploration locations globally for the discovery of world class orogenic gold deposits. The shield, including both Guyana and Surinam, contain large relatively underexplored greenstone belts, from which Reunion Gold expects many more significant gold discoveries could emerge in the coming years.

Oko West Project

Reunion Gold’s Oko West Project is a brand-new gold discovery in northwest Guyana located within the historical Oko gold district. Alluvial gold has been mined from the Oko district since the turn of the century, but very little primary gold has been mined or even explored for to the best of the company’s knowledge. The project comprises a prospecting license with an area of approximately 44 square kilometers and is 100% held by Reunion’s Guyanese subsidiary.

In 2020, Reunion Gold’s geochemical survey, trenching and initial 1000 m drill program discovered and confirmed the presence of gold mineralization in this Orogenic gold system. The gold occurs in the eastern edge of the project area, along a 6km long sheared contact between a granitoid intrusion and a meta volcanic-meta sedimentary rock package. The MRE is located within the Kairuni zone, which represents the northern most 1.9 km of the 6 km long contact.

“We are advancing our Oko West project along two tracks. The first is to advance the exploration programs outside of the Kairuni zone, aimed at outlining and discovering additional gold mineralization within our Prospecting License. On this front, I am very excited by the results from the initial Scout RC Geochem drill program that is defining new targets west of our Kairuni zone,” Rick Howes, President and CEO of Reunion Gold, stated in a recent news release. In addition to the targets west of the Kairuni zone, the company has also commenced exploration work on the southern ~ 4 km of the same sheared contact that hosts the Kairuni zone MRE. In addition, the company feels that the MRE marks the size of the Kairuni resource at a point in time and that there is good potential to continue to grow the resource. The MRE remains open at depth below the resource pit outline in the block 4 area and also to depth and along strike in the block 5 and 6 areas. In addition to the exploration programs, the second strategic track is to rapidly advance the Kairuni zone along the path to development. To that end the company is moving forward with the engineering and other studies, including more detailed metallurgical studies, that will support the release a PEA on the Kairuni zone by year end 2023 The company feels that the rapid advancement of development of Kairuni zone MRE, while in parallel continuing to explore for additional ounces on the project, is the best path to try and maximize shareholder value in the shortest period of time.

Guyana

Guyana boasts a long history of mining gold, bauxite, diamonds and manganese. Still, the greenstone belts of the Guiana Shield remain relatively unexplored when compared to the analogous regions of the West African Shield (Birimian), which, according to geological evidence, was once connected to the Guiana Shield, forming a contiguous craton prior to the Mesozoic period.

Despite a historical lack of accessibility and low exploration intensity, several significant large-scale projects have emerged in the Guiana Shield, including Aurora, Oko West, Oko Main, Toroparu and Omai. Guyana is English speaking with a British based parliamentary and legal system and boasts the world’s fastest growing economy on the back of significant offshore oil discoveries by Exxon and its partners. It is expected that a significant amount of the revenues from oil production will be invested in improving the infrastructure, education and health care and agriculture within the country.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, called 2022 the “strongest year for gold demand in over a decade.” Annual gold demand jumped 18% YoY due to “colossal central bank purchases, aided by vigorous retail investor buying and slower ETF outflows.”

Despite this spike in demand, total annual gold supply increased by just 2% in 2022, halting two years of successive declines but failing to challenge 2018 highs. This supply-demand imbalance could provide a favorable market environment as Reunion Gold continues to advance drilling programs at its 100%-owned Oko West Project.

Management Team

Successful exploration and the discovery of significant deposits in any given region require immense amounts of local knowledge and experience. This is the principle around which Reunion Gold has built its management team. In total, the company’s leadership boasts over 225 years of combined experience in the Guiana Shield.

David Fennell is the Executive Chairman of Reunion Gold, a position he has held since the company’s inception in 2003. He has 40 years of experience in the mining industry. He received a law degree from the University of Alberta in 1979 and practiced law until he founded Golden Star Resources Ltd. in 1983. During his term as President and CEO, Golden Star became one of the largest and most successful exploration companies. While at Golden Star, he was instrumental in the discovery and development of the Omai Gold Mine in Guyana and the Gross Rosebel Mine in Suriname. In 1998, Mr. Fennell became Chairman and CEO of Hope Bay Gold Corporation. He held this position through the merger of Hope Bay and Miramar Mining Corporation and remained as Executive Vice-Chairman and Director for the combined entity until its takeover by Newmont Mining Corporation in 2008. Mr. Fennell is currently a member of the board of directors of G Mining Ventures Corp. and Sabina Gold & Silver Corp.

Rick Howes, P.Eng., is the company’s President and CEO. He is a seasoned mining executive with over 39 years of experience in the mining industry, most recently as CEO of Dundee Precious Metals. Mr. Howes has extensive operating, technical and project development experience in both underground and open pit mines throughout Canada and internationally. In 2009, Mr. Howes joined Dundee Precious Metals, where, as VP and General Manager, he led the transformation of the Chelopech Mine in Bulgaria to reach world-class levels of performance. He became COO in 2011 and oversaw several significant growth capital development projects, including the expansion of the Chelopech Mine, the upgrade and expansion of the Tsumeb Smelter in Namibia and the development of the greenfield Ada Tepe open pit gold mine in Bulgaria. He was appointed CEO in April 2013, leading Dundee’s transformation from a junior gold producer to a multi-asset mid-tier gold producer generating strong free cashflow and solid returns to shareholders. Mr. Howes has been recognized as a visionary leader in mining, organizational innovation and transformation and was recognized as the Outstanding Innovator of 2016 by the International Mining Technology Hall of Fame.

Alain Krushnisky is the CFO of Reunion Gold. He brings to the company years of experience in the mining sector, including 10 years with Cambior Inc. (now IAMGOLD) in capacities such as Vice-President and Controller. Since 2004, Mr. Krushnisky has been doing consulting work for various publicly listed exploration and mining companies. He graduated from the University of Ottawa in 1983 with a bachelor’s degree in commerce and is a Chartered Professional Accountant.

Justin van der Toorn is the company’s VP Exploration. He is an exploration geologist with 18 years’ experience in the minerals industry, leading and managing exploration teams from grassroots activities through to discovery and resource definition drilling. Mr. van der Toorn’s previous experience has been in a range of commodity and deposit styles, including extensive work in Carlin-style gold, low- and high-sulphidation epithermal, porphyry and orogenic gold systems. He holds an MSci degree in Geological Sciences from the Royal School of Mines, Imperial College London. He is registered as a Chartered Geologist (CGeol) of the Geological Society, and a European Geologist (EurGeol) by the European Federation of Geologists.

Doug Flegg is the company’s business Development advisor. Doug has over 35 years’ experience in mining and mining finance with senior positions in research, portfolio management and global equity sales. Previously, Mr. Flegg was Managing Director Global Mining Sales with BMO Capital Markets where he was involved in raising $35 billion in over 200 corporate financings. Since 2016 he has been providing business development, strategic, and financing advice to corporate mining clients. Mr. Flegg also has a B.Sc. in Geology, work experience as a geologist and an MBA from Queens University.

Reunion Gold Corp. (OTCQX: RGDFF), closed Thursday's trading session at $0.345825, up 1.7132%, on 199,991 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.24/$0.46.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

In the global entertainment and media sector, video gaming is the highest-grossing industry. The industry has more than three billion individuals who enjoy gaming in one form or another. Steam, launched by Valve Corp more than 20 years ago, established a unified ecosystem for gamers that allowed the company to purchase games through convenient storefronts and customize their gamer tags. However, with different online ecosystems, platforms and technologies popping up nowadays, it has become challenging for gamers to keep up. It doesn't help either that game libraries are now segmented, because this has made it a requirement to have different accounts to launch a game, each with its own authentication protocol. Away from gaming, fintech companies such as Horizon Fintex are also taking strides in helping to merge the latest technologies in Web3 with traditional finance systems on Wall Street so that capital mobilization can be deepened in a way that increases transparency, efficiency, compliance and security.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: 4TG) (OTC: AUHIF)

The QualityStocks Daily Newsletter would like to spotlightFathom Advanced Gold Exploration Inc. (CSE: AUHIF) (FSE: 4TG) (OTCQB: AUHIF) .

Advanced Gold Exploration (CSE: AUEX) (OTC: AUHIF) (FSE: 4TG) has announced a proposed debt settlement of $16,650. The settlement was made with an arm's length creditor of the company. In order to settle the debt, the company issued 602,410 common shares in the capital of the company; the shares were issued for $0.05 per common share. The issued common shares are subject to a four-month hold period. The announcement noted that the transaction is subject to final acceptance of the Canadian Securities Exchange.

To view the full press release, visit https://ibn.fm/hH7xP

Advanced Gold Exploration Inc. (CSE: AUEX) (OTC: AUHIF) (FSE: 4TG), formerly Advance United Holdings Inc., is a junior mining company bringing an entirely different approach to the mining industry. Advanced Gold Exploration doesn’t intend to become a mining company. Rather, it has acquired a portfolio of undervalued gold properties and is increasing their value through the application of modern technology. The object is to eventually monetize the projects to add value for its shareholders.

Advanced Gold Exploration has a growing pipeline of similar properties that it is looking to acquire. The company is involved exclusively in the acquisition and advancement of past gold projects – with no intent to bring them back into production. It leaves the actual gold mining to others who are experts in that area.

Advanced Gold Exploration’s expertise is in identifying and acquiring undervalued properties with significant historical work which were previously not economically viable, but that the company believes have economic value at today’s gold prices. Advanced Gold Exploration funds the reworking of historic data and applying modern technology to underwrite new qualified reports that document quantifiable resources and reserves to current standards, thereby recognizing the current value of the projects.

The company’s purpose is to bring immediate and long-term value to its partners and shareholders while seeking to eliminate exploration risk. Advanced Gold Exploration believes that the future of gold is strong, and it will be part of that future.

The company is headquartered in Toronto.

Projects

The Melba Property is the site of a former producing gold mine located about 15 kilometers north of the gold mining center of Kirkland Lake, Ontario. The project is located in the Abitibi Greenstone Belt, part of the largest gold producing area of Canada. Visible gold can be identified in quartz veins on the surface and high-grade gold intersections have been obtained in drilling by AUEX. No exploration has been carried out on the extensions of the veins to the north or south of the surface exposures in swamp covered areas.

The Doyle Property lies in the Batchawana Greenstone Belt located north of Sault Ste. Marie, Ontario. Past drilling identified high-grade gold deposits in three areas of the property. Follow up studies are needed on all three sites. Exploration has not been carried out to follow-up the high-grade gold intersections. Further work will focus on expanding the areas of known gold mineralization.

The Landrum Property in Edgefield County, South Carolina, is in the Carolina Gold Belt, home of at least five past producing gold mines and one currently producing gold mine. The area was the site of the first gold rush in the U.S. in the early 1800s, predating 1849 California. The area has recently become of interest due to gold bearing intersection on a nearby property where 62.5 meters graded 8.5 G/t gold in a recent drillhole. Gold can still be panned in some streams in the area. Identified veins consist of silicified zones generally made up of 20-50% and vary in thickness from less than a meter to 10 meters.

The Paint Lake Road Property is located in Wawa, Ontario, and is less than five kilometers from Wesdome’s operating Mishi Open Pit gold mine. Gold deposits have been found to the north, east and south of the property. A recent geophysical survey on the neighboring property has pointed to a prospective mineralized horizon which appears to trend onto the property.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

Recently the gold price has reached new highs on multiple days and is tracing a trend upward.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Management Team

James Atkinson, M.Sc., P. Geo., is CEO of Advanced Gold Exploration. An experienced exploration geologist and project manager with over 50 years of experience, he has spent his career in mineral exploration and mining. He has designed and managed multimillion dollar programs searching for and discovering various commodities, including industrial minerals. These projects involved geophysical, geochemical and drilling programs, as well as prospecting and geological mapping. He has also negotiated options and purchase deals for mineral properties and raised financing for exploration. He recently completed a transaction which resulted in cash and shares to the company. The result was a special distribution of publicly trading shares to the existing shareholders.

Andrew Ramcharan, Ph.D., P. Eng., is President of Advanced Gold Exploration. He has 20 years’ unique experience in the mining industry, which includes investor relations, project evaluation, operations, capital markets, consultancy and investment banking. He has a track record of growing companies significantly, with recent success at Roscan Gold with over $100 million of value creation in less than 14 months. He has created and implemented investor relations policies and corporate strategies with significant success. He completed over 300 project evaluations globally on many commodities, proposed over 40 for different investment strategies and completed two majors take over (worth of $800 million and $1.5 billion in capital cost). He directly assisted in putting four mines in production and significant growth of numerous companies, including IAMGOLD. At Sprott, he was conducting project evaluation and successfully deployed over $500 million – the most deals in any year.

Radovan Danilovsky, CIM, is CFO of Advanced Gold Exploration. He is an experienced small-cap executive in the junior mining sector. He is also an experienced investment manager and currently is a registered Portfolio Manager with Wealthera Inc. He has served as a Managing Director, Portfolio Manager and Chief Compliance Officer of Orthogonal Capital Management Corp. Prior to that, he was an investment analyst at Accilent Capital Management Inc. He is a graduate of the University of Toronto and earned master’s degrees from UPMC Sorbonne University and ESSEC Business School in Paris.

Advanced Gold Exploration Inc. (OTC: AUHIF), closed Thursday's trading session at $0.02, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0109/$0.095.

Recent News

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Diamond Lake Minerals (OTC: DLMI) is a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens. The company was featured in a new Benzinga Crypto article that discussed DLMI's favorable positioning in tokenization attributed to its innovative technology, infrastructure and leadership. "DLMI has spent a substantial amount of time and resources under the leadership of its CEO Brian J. Esposito working on the program of converting real estate assets into blockchain-based digital tokens in its ecosystem… A big part of DLMI's strategy was its recent acquisition of Avrio Worldwide PBC, a registered market infrastructure provider with a full technology stack. Avrio will deploy its registered digital financial market infrastructure (‘dFMI') for the tokenization of digital assets across the DLMI network of companies in spaces like financial services, real estate, media, entertainment, gambling and more. This interoperability is key to the mass adoption of digital assets and tokenization," the article reads. "While DLMI is working to create a strong infrastructure, it is also investing in its leadership. The company just announced it is bringing in Douglas Borthwick as advisor and chief token strategist. With over 30 years of experience in the finance industry, he has held significant positions at INX Limited and INX Digital Company (OTCQB: INXDF)."

To view the full article, visit https://ibn.fm/0Ri7H

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Thursday's trading session at $5.02, off by 1.5686%, on 211 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$5.90.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that it will focus on glucagon-like peptide 1 ("GLP-1") applications of its patented DehydraTECH(TM) technology for diabetes and weight loss for the 2024 calendar year. "This comes hot on the heels of a successful, active year of R&D in 2023, a year that saw significant strides in developing its patented DehydraTECH technology including its new foray into GLP-1 drugs… This laid the groundwork for Lexaria to explore a new class of molecules it had never worked on before, ultimately quietly launching its top-priority and unpublicized early-stage work program – GLP-1 – for weight loss and diabetes control. In the words of Chris Bunka, Lexaria's CEO, this was a ‘high-risk program,' mainly because this class of drugs is considered ‘large molecules,' yet all of Lexaria's previous investigations were concentrated on ‘small molecules.' However, by the end of November and early January 2024, the company reported positive interim and final human pilot study results using a single semaglutide dose of a Rybelsus(R) tablet to a matching dose from Rybelsus that had been compound formulated in capsule form using DehydraTECH processing technology enhancements," a recent article reads. "Our R&D plans for 2024 are very tightly focused and will be concentrated mainly on GLP-1 investigations," said Lexaria CEO Chris Bunka. "Given the overwhelming interest in the GLP-1 sector, this will be a main focus."

To view the full article, visit https://ibn.fm/fVTRr

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Thursday's trading session at $3.63, off by 2.1563%, on 168,460 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6488/$6.85.

Recent News

SUIC Worldwide Holdings Ltd. (OTC: SUIC)

The QualityStocks Daily Newsletter would like to spotlightFathom SUIC Worldwide Holdings Ltd. (OTC: SUIC) .

SUIC Worldwide Holdings Ltd. (OTC: SUIC) provides research and development, venture financing and investment for private and public companies that develop products and services in the areas of Internet of Things, cloud computing, mobile payments, Big Data, blockchain, artificial intelligence and global franchising. The company seeks to enhance and streamline existing processes and establish new and exciting business models that will create revolutionary products and services.

SUIC is the largest shareholder and major operating partner of Beneway Holdings Group. The I.Hart Group, a subsidiary of Beneway, currently operates 150 global chain and franchised locations under a variety of brands. It is working on integrating more successful chains to enter the U.S. chain and franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. real estate firms, shopping malls and associated groups to expand and achieve its target of 750 chain and franchise locations in the near future.

The company is headquartered in Flushing, New York, with offices in San Francisco, Taiwan and Malaysia.

Portfolio

SUIC works with Beneway in several business ventures, with focus on the following:

  • Fintech – Through Boom Fintech, the major subsidiary of Beneway USA, the company holds nine revolutionary fintech patents. Boom Fintech integrates payment systems, electronic invoice devices, mobile cash registers, POS system devices and ERP, as well Big Data + AI and other services, to ALL-IN-ONE products that provide standardized intellectual property that’s modular to all industries, from chain department stores to night market vendors. Beneway Holdings Group connects borrowers and lenders, building strategic partnerships by bridging the various stakeholders to provide a holistic financial delivery ecosystem and to integrate advanced systems and finance its global merchants and franchisees.
  • Food Industry Supply Chain Integration – SUIC and Beneway will partner with international trade financiers to support the huge demand for raw material import/export between the U.S. and Asia. SUIC and Beneway are looking to raise funds from an IPO and the capital markets to support mergers and acquisitions of U.S. mid- and upper-stream food industry suppliers.
  • Global Chain and Franchise Expansion – Through I.Hart catering group, SUIC and Beneway are working to bring reputable and distinguished overseas food product brands to the U.S. and around the world. It is working on integrating more successful chains to enter the U.S. chain and franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. real estate firms, shopping malls and associated groups for faster expansion.
  • Other Supply Chain Integration – Beneway has identified several additional industries for future expansion, including medical and health care, high-tech digital AI systems, environmental protection and energy-related production.

Market Opportunity

An analysis by Growth Market Reports, a full-service market research and business consulting organization, estimated that the value of the global Asian food market was $437.15 billion in 2022. The market value is projected to reach approximately $805.08 billion by 2031, expanding at a CAGR of 7.1% during the forecast period.

Asian cuisine is well known for its diversity, with a wide range of flavors, ingredients and cooking techniques influenced by various factors such as climate, geography, history and cultural practices. The report states that Asian food outlets are expanding at a tremendous rate in the U.S. and Europe due to rising consumer demand. Demand is driven by various factors, including the growing interest in global authentic flavors and the nutritional benefits that Asian food offers. Consumers have become increasingly exploratory with their food choices, according to the report.

McKinsey Consultants estimate that, by 2025, the global supply chain financial market will reach $20 trillion. At present, 60% of the global participants are small and medium-sized retail companies, representing the target customers of SUIC and its subsidiary. Recent Juniper Research shows that global digital commerce transaction value will also pass $20 trillion by 2027.

Management Team

Hank Wang is CEO of SUIC. Since 2018, he has served as CEO of the I.Hart Group. Prior to joining I.Hart, he was Secretary General of Taiwan Quantitative Hedging Development Association. He graduated from Tamkang University in Taiwan with a Bachelor of Finance degree.

Elena Lin is associate CFO of SUIC. She previously served as CEO of Monga Chicken. In 2015, she was recognized as one of Taiwan’s Top 100 Managers of the Year. She holds a master’s degree from the Kaohsiung University of Hospitality and Tourism’s Institute of Food Culture and Catering Innovation in Taiwan.

Elton Han is associate CTO of SUIC. He is also currently Director of Food and Beverage Development for the I.Hart Group. He also holds a position with the Taiwan International Young Chefs Association. He previously served as Executive Chef of Hanbilou, Huashan Guanzhi, Daye Group.

SUIC Worldwide Holdings Ltd. (OTC: SUIC), closed Thursday's trading session at $1.8, even for the day, on 40 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.95/$3.00.

Recent News

Life Electric Vehicles Holdings Inc. (OTC: LFEV)

The QualityStocks Daily Newsletter would like to spotlightFathom Life Electric Vehicles Holdings Inc. (OTC: LFEV) .

Life Electric Vehicles Holdings Inc. (OTC: LFEV) (d/b/a Life EV Group), along with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. The company’s business model focuses on the launch, acquisition and consolidation of multiple brands of e-bikes, e-trikes, e-scooters and light EVs with the aim of positioning itself as an industry leader for the American micro-mobility market.

The light electric vehicle industry, mainly e-bikes, is fast becoming a leading form of EV sales in the U.S. and Europe. In addition to offering ready-to-ride electric vehicles, Life EV Group intends to distribute individual components, including motors, batteries, chargers, controllers and EV parts, to third party manufacturers in both the U.S. and worldwide.

The company’s first acquisition was completed in 2023 with a 40% equity stake in LEV Manufacturing Inc., a related company and American manufacturer of e-bikes. LEV Manufacturing’s assembly utilizes free-trade zone processes with a U.S. Certificate of Origin, eliminating middle layer costs and resulting in cost-effective production and lower MSRPs.

LEV Manufacturing recently completed the acquisition of Serial 1 Cycle Company LLC. Serial 1 is an e-bike maker founded by U.S. motorcycle manufacturer Harley-Davidson in 2018 and spun off as an independent brand in 2020. The acquisition positions Serial 1 for even greater success and long-term growth.

Life EV Group is headquartered in Deerfield Beach, Florida.

Market Opportunity

An analysis from Mordor Intelligence, a market research and advisory firm, estimates the e-bike market to be worth $34.98 billion in 2024 and projects it will expand to reach a value of $51.78 billion by 2029, representing a CAGR of 8.16% during the forecast period.

Mordor attributes forecast market growth primarily to the increasing adoption of electric bikes as a mode of daily transportation around the world. The market is seeing an upsurge in unit sales based on their attractive consumer characteristics, including health benefits, affordability and convenience.

The North American electric bike market is growing as the preference for low-speed two- and three-wheelers has increased in recent years. Various bike-sharing operators are including electric bikes in their fleets, which is expected to support the sales growth of these bikes in the near future.

Management Team

Robert Provost is the CEO of Life EV Group. He was Founder and CEO of Prodeco Technologies, a maker of e-bikes and e-bike parts and accessories. He also serves as President and CEO of LEV Manufacturing Inc. He is Chairman of the board for Serial 1 Cycle Company.

Daniel Del Aguila is COO at Life EV Group. He co-founded Prodeco Technologies and serves as COO of LEV Manufacturing Inc.

Ivan Drusc is CFO at Life EV Group. He is a seasoned accounting and finance professional with a proven track record in industries from insurance to IT and property management. He has served as a key player in businesses ranging in size from startups to publicly traded global companies. He has experience in cost reduction, risk mitigation, IT and ERP systems, outsourcing and restructuring. He is a graduate of the University of Akron with a bachelor’s degree in accounting.

Life Electric Vehicles Holdings Inc. (OTC: LFEV), closed Thursday's trading session at $0.65, even for the day. The average volume for the last 3 months is 169 and the stock's 52-week low/high is $0.25/$1.25.

Recent News

Starco Brands Inc. (OTCQB: STCB)

The QualityStocks Daily Newsletter would like to spotlight Starco Brands Inc. (OTCQB: STCB).

Starco Brands Inc. (OTCQB: STCB) is a modern-day invention factory. The company’s unwavering mission is to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

This consumer product company has grown from a few million dollars in revenue to a current run rate of approximately $67 million in annual revenue in one year.

The company has succeeded by identifying whitespaces in eight core consumer categories and then either: 1) leveraging its internal R&D capabilities and dedicated manufacturing network to invent new technologies and brands or 2) utilizing the management team’s extensive M&A experience to acquire brands that fill the industry void, delighting consumers and retailers alike.

Whether the brand is developed internally or acquired, the company employs a modern marketing playbook to ensure its brands are at the forefront of culture; garnering unprecedented media attention and engagement that supports a robust sales network.

Starco Brands’ core competencies are inventing technologies, acquiring companies, marketing, building trends, pushing awareness, penetrating media (social and otherwise) and executing cutting edge pull-through strategies with a roster of globally recognized celebrities, influencers and media and distribution partners.

A commitment to changing the way people approach everyday activities is innate in the company’s corporate DNA.

The company is based in Santa Monica, California.

Brands

Whereas other consumer products companies are content with evolution, Starco Brands has its mind set on creating a revolution across the industry. From disrupting the spirits industry with Whipshots, the world’s only vodka-infused whipped cream, to Soylent, the original food tech company, Starco Brands is putting the CPG world on notice. Its portfolio of brands includes:

  • Whipshots is a first-of-its-kind alcoholic whipped cream launched in 2021 with celebrity partner Cardi B. Consumers have embraced this boozy concoction, putting it on top of cocktails, coffees and desserts, or enjoying it straight from the can. In just over a year, the brand has sold over 2 MILLION cans, making it one of the fastest growing spirits in history.
  • Winona Pure gives consumers movie theatre popcorn in the comfort of their own homes. All the flavor and none of the additives is the story behind these all-natural, non-GMO popcorn seasoning sprays. A simple spray is all it takes to add the perfect pop of flavor to the classic theatre treat.
  • Art of Sport, co-founded by the great Kobe Bryant, is the number one body care brand for athletes. With a growing line of personal care products tested by the world’s greatest athletes, these daily skin essentials give consumers everything they need to feel fresh, stay protected and confident and perform at their peak every day.
  • Skylar is the first and only line of perfumes on the market that are hypoallergenic and safe for sensitive skin. With the strong support of industry titan Sephora, the brand has quickly attracted a loyal following.
  • Soylent is a technological feat. Originally funded by Google Ventures and Andreessen Horwitz, Soylent is dubbed as the world’s most perfect food. Made from sustainably grown plant-based ingredients, Soylent’s line of products is scientifically developed to provide all the functional ingredients, vitamins, minerals, fats, carbohydrates and protein that the body needs – all in convenient, delicious and affordable packages. Soylent’s innovative product line-up includes complete nutrition powders, ready-to-drink shakes, 100-calorie snack bars, high protein nutrition shakes and energy boosting nutrition shakes. Soylent was also the recipient of the 2023 Product of the Year Award by Kantar, a global leader in consumer research.

With award-winning marketing talent, Starco Brands develops robust, integrated marketing plans for every brand in its portfolio, ensuring an impactful presence across all verticals.

Market Outlook

Starco Brands’ varied brand portfolio gives it access to the growth of numerous product categories that are ripe for innovation.

Through its February 2023 acquisition of complete nutrition pioneer Soylent, Starco Brands is positioned to capitalize on the projected growth of the plant-based nutrition space. Research firm Statista valued the plant-based nutrition market at $29.4 billion in 2020 and forecasts its value at nearly $162 billion by 2030, representing a CAGR of 18.7% for the period.

Likewise, Starco Brands gained improved access to the global fragrance market through its December 2022 acquisition of Skylar. According to a report by Grand View Research, the global perfume market was valued at $50.85 billion in 2022 and is expected to grow to a value of nearly $80 billion by 2030, achieving a CAGR of 5.9% over the forecast period.

The company is primed to expand its access to other growth verticals as it advances on its path to invent and acquire behavior-changing technologies and brands.

Management Team

Ross Sklar is the CEO of Starco Brands. A chemical formulator by trade, he started his first company while still in college. Since 2004, he has made over a dozen acquisitions with multiple exits and controls an eclectic collection of industrial, household, personal care and food and beverage manufacturers covering many consumer-packaged goods categories.

Darin Brown is the Chief Operating Officer of Starco Brands. With over 20 years of experience in chemical manufacturing, business development, finance and mergers and acquisitions, he has scaled the company from the ground up. He oversees all internal operations for Starco Brands and is an integral liaison between the company and Mr. Sklar’s manufacturing facilities.

David Dreyer is Chief Marketing Officer of Starco Brands. With over 25 years of experience working with blue chip and startup brands, he oversees all marketing initiatives for the company. Mr. Dreyer comes to Starco having worked with such standout brands as Apple, Pepsi, Pizza Hut, Dr Pepper, Snapple, Infiniti, The GRAMMY’s, Honda and Stamps.com. He is also a Professor of Advertising at USC’s Annenberg School for Communication.

Starco Brands Inc. (STCB), closed Thursday's trading session at $0.13679, up 12.123%, on 290,329 volume. The average volume for the last 3 months is 36,424 and the stock's 52-week low/high is $0.115/$0.20.

Recent News

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.

Projects

Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Arizona Metals Corp. (OTCQX: AZMCF), closed Thursday's trading session at $1.4575, up 3.685%, on 317,506 volume. The average volume for the last 3 months is 125,301 and the stock's 52-week low/high is $1.21/$3.40.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.